Maple Capital Management, Inc. Abbott Laboratories Transaction History

Maple Capital Management, Inc.

$1.31 Billion
Q3 2024

A detailed history of Maple Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Maple Capital Management, Inc. holds 169,736 shares of ABT stock, worth $20.1 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

169,736

Previous 169,289 0.26%

Holding current value

$20.1 Million

Previous $17.6 Million 10.01%

% of portfolio

1.48%

Previous 1.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $44,731 - $52,804	447 Added 0.26%	169,736 $19.4 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $165,197 - $184,401	1,640 Added 0.98%	169,289 $17.6 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $113,572 - $125,435	1,037 Added 0.62%	167,649 $19.1 Million
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $121,125 - $148,267	1,343 Added 0.81%	166,612 $18.3 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $77,761 - $93,300	-814 Reduced 0.49%	165,269 $16 Million
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $136,355 - $151,928	-1,353 Reduced 0.81%	166,083 $18.1 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $118,944 - $140,004	-1,228 Reduced 0.73%	167,436 $17 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $152,476 - $178,878	-1,604 Reduced 0.94%	168,664 $18.5 Million
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $6,676 - $7,730	69 Added 0.04%	170,268 $17.4 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $40,725 - $49,224	399 Added 0.23%	170,199 $18.5 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $469,534 - $572,566	-4,118 Reduced 2.37%	169,800 $20.1 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $765,039 - $936,748	-6,622 Reduced 3.67%	173,918 $24.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $210,571 - $232,953	-1,805 Reduced 0.99%	180,540 $21.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $210,945 - $248,312	1,994 Added 1.11%	182,345 $22.4 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $305,731 - $360,198	2,809 Added 1.58%	180,351 $21.6 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $261,240 - $284,676	-2,488 Reduced 1.38%	177,542 $19.4 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $95,488 - $115,964	-1,042 Reduced 0.58%	180,030 $20.3 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $624,581 - $799,386	-8,157 Reduced 4.31%	181,072 $16.6 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $192,543 - $281,550	-3,065 Reduced 1.59%	189,229 $14.9 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $100,806 - $112,221	1,284 Added 0.67%	192,294 $16.7 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $55,242 - $59,899	675 Added 0.35%	191,010 $16 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $7,725 - $9,010	106 Added 0.06%	190,335 $16 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $336,132 - $406,384	-5,076 Reduced 2.6%	190,229 $15.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $786,129 - $890,571	11,991 Added 6.54%	195,305 $14.1 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $181,821 - $219,346	-2,990 Reduced 1.6%	183,314 $0
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $280,193 - $309,249	4,867 Added 2.68%	186,304 $0
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $154,855 - $175,082	-2,752 Reduced 1.49%	181,437 $0
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $117,934 - $126,261	-2,197 Reduced 1.18%	184,189 $10.5 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $8.96 Million - $10 Million	186,386	186,386 $9.95 Million

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.

Account

Maple Capital Management, Inc. Abbott Laboratories Transaction History